Browse studies
Find your next paid study
38 recruiting studies matching your filters
Phase 1
An Open-label, Phase Ib Study to Assess the Safety and Clinical Activity of CYAD-101 Administered Concurrently With FOLFOX Chemotherapy, Followed by Pembrolizumab Treatment, in Patients With Metastatic Colorectal Cancer
The purpose of the CYAD-101-002 study is to assess the safety and clinical activity of CYAD-101 in patients with unresectable metastatic colorectal cancer admi…
Unresectable Metastatic Colorectal Cancer
Celyad Oncology SANCT04991948
Phase 1
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
To learn if the drug combination of adagrasib, cetuximab, and cemiplimab can help to control metastatic CRC with KRAS G12C mutations.
Metastatic Colorectal CancerKRAS G12C Mutations
M.D. Anderson Cancer CenterNCT06412198